Description
An 11β-HSD inhibitor; inhibits 11β-HSD1 activity in isolated liver and decreases blood glucose and insulin concentrations in a mouse model of hyperglycemia and hyperinsulinemia at 100 mg/kg; decreases the expression of MCP-1 and TNF-α in adipose tissue and reduces body weight and improves glucose tolerance and insulin sensitivity in a mouse model of high-fat diet-induced obesity; decreases TNF-α, IL-1β, IL-6, and IL-17 protein levels in serum and reduces severity of collagen-induced arthritis in mice
Formal name: 3-chloro-2-methyl-N-[4-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-2-thiazolyl]-benzenesulfonamide
Synonyms:
Molecular weight: 429
CAS: 376640-41-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Sterol Biosynthesis||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Obesity